Rapid-Acting Insulin Biosimilar Receives FDA Approval for Diabetes - Pharmacy Times

Retrieved on: 2025-02-14 21:24:05

Tags for this article:

Click the tags to see associated articles and topics

Rapid-Acting Insulin Biosimilar Receives FDA Approval for Diabetes - Pharmacy Times. View article details on hiswai:

Excerpt

Key Takeaways. Insulin-aspart-szjj (Merilog) is approved as a biosimilar to insulin aspart (Novolog) for diabetes management.

Article found on: www.pharmacytimes.com